About

About Us

A subsidiary of the Group, DAL Medical Services Company Ltd. (DMS) was founded in 1997 and began operations as a distributor of Forceval, owned by Unigreg Limited. Through a series of agency agreements for distribution, sale and marketing of pharmaceutical brands, DMS has grown into one of the leading pharmaceutical and healthcare dealerships in Sudan. In 2010, DMS acquired K.A. Bodourian, an already established brand with 60 years of success behind its name.

To improve Sudanese Health-care by Providing High Quality Pharmaceutical Products


• Satisfying our clients and partners’ requirements and expectations.
• Adding value, whilst simultaneously contributing to the ongoing development of Sudan’s healthcare through the provision of high quality, value added products and services.
• Growing profitably through our commitment to high standards, operational capabilities and leveraging our expertise.
• Support DAL Group in being a better, more responsible company through behaving responsibly and caring about the wider impact of our actions.


• We focus on our customers, offering them best-in-class products and services while building long-term relationships.
• We strive to maintain a diverse workforce where people are valued and treated solely on merit and competence, irrespective of gender, beliefs, and ethnicity.
• We build world-class operations, leading the way for others in the region, and are committed to the social, environmental and economic development of Sudan and the region.
• We have no political affiliations, observe the law at all times, and act with integrity and honesty.
• We aim to be a global leader in responsible business and do not engage in activities that harm people or the environment.

Chairman's Message

OSAMA DAOUD ABDELLATIF
Chairman, DAL Group

We believe that our strength is derived from the diversity of both our people and our customers; we have the privilege of dealing with a range of businesses and consumers across many sectors. We touch the lives of people every day through our products and services, and as much as we believe that is a privilege, we realize the great responsibility that comes with it.
Our focus on quality will ultimately lead to improved financial and operational excellence. We are committed to growth in our existing business and new ones, all along aiming at the highest operating standards. It is this commitment that motivates our considerable investment in innovation, product development and quality systems; the driving force behind the Group’s constant pursuit of excellence.
We will work systematically to achieve continuous improvements, setting targets, adding value, and measuring progress. It is very important that our deeds match our aspirations.

OSAMA DAOUD ABDELLATIF
Chairman, DAL Group

Managing Director's Message

MOTASIM DAOUD ABDELLATIF
DED MD, DAL Group

To become a Regional Company, we must have the right people in place, we need to be creative and have the ability to develop and to have a vision but also resilience in delivering this vision.

MOTASIM DAOUD ABDELLATIF
DED MD, DAL Group
OUR VALUE CHAIN

Focus on sustained supply of goods to meet the market demand and enhance customers satisfaction through Quality Management System which ensure high integration of quality throughout the value chain and operate with integrity and transparency across:

REGULATORY AFFAIRS

SUPPLY CHAIN END TO END

SALES

Maintaining excellent knowledge of local, regional and international regulatory guidelines and good, professional communication with the health authorities.

Ensure availably and continues flow of products through good regulatory practices (licensing, registration and importation).

Managing end to end supply chain with special focus on product quality and integrity through different phases of product handling and insure complying with cGSP & cGDP.

Managing customer relationship and dealing with complaints
Develop strategic alliances with key customers through customized services, leading to continuous customer growth & retention.
Insure comprehensive market coverage and building strong relationships with customers, both in private & public sector

REGULATORY AFFAIRS

Maintaining excellent knowledge of local, regional and international regulatory guidelines and good, professional communication with the health authorities.

Ensure availably and continues flow of products through good regulatory practices (licensing, registration and importation).

SUPPLY CHAIN END TO END

Managing end to end supply chain with special focus on product quality and integrity through different phases of product handling and insure complying with cGSP & cGDP.

SALES

Managing customer relationship and dealing with complaints
Develop strategic alliances with key customers through customized services, leading to continuous customer growth & retention.
Insure comprehensive market coverage and building strong relationships with customers, both in private & public sector